Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI)
Por:
Misery, L, Weisshaar, E, Brenaut, E, Evers, AWM, Huet, F, Stander, S, Reich, A, Berardesca, E, Serra-Baldrich, E, Wallengren, J, Linder, D, Fluhr, JW, Szepietowski, JC, Maibach, H, Honari, G, Le Gall-Ianotto, C, Takamori, K, Richters, R, Int Forum Study Itch ISFI
Publicada:
1 feb 2020
Ahead of Print:
1 oct 2019
Resumen:
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin - as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin.
Filiaciones:
Misery, L:
Univ Hosp Brest, Dept Dermatol, Brest, France
Weisshaar, E:
Heidelberg Univ, Dept Dermatol, Occupat Dermatol, Heidelberg, Germany
Brenaut, E:
Univ Hosp Brest, Dept Dermatol, Brest, France
Evers, AWM:
Fac Social & Behav Sci, Dept Hlth Med & Neuropsychol, Leiden, Netherlands
Huet, F:
Univ Hosp Brest, Dept Dermatol, Brest, France
Stander, S:
Univ Hosp Munster, Ctr Chron Pruritus, Dept Dermatol, Munster, Germany
Reich, A:
Univ Rzeszow, Dept Dermatol, Rzeszow, Poland
Berardesca, E:
San Gallicano Dermatol Inst, Rome, Italy
Serra-Baldrich, E:
Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain
Wallengren, J:
Skane Univ Hosp, Dept Dermatol & Venereol, Lund, Sweden
Linder, D:
Univ Oslo, Sect Biostat, Oslo, Norway
Fluhr, JW:
Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
Szepietowski, JC:
Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
Maibach, H:
Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA USA
Honari, G:
Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA USA
Le Gall-Ianotto, C:
Univ Hosp Brest, Dept Dermatol, Brest, France
Takamori, K:
Juntendo Univ, Urayasu Hosp, Dept Dermatol, Chiba, Japan
Richters, R:
Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands
Green Published
|